Outgoing Roche ($RHHBY) Chairman Franz Humer will get a bonus when he leaves next year, Vice Chairman Andre Hoffman told shareholders. But it will be "completely different" from the $76 million fellow Swiss drugmaker Novartis ($NVS) originally planned to pay ex-chairman Daniel Vasella. Roche stockholders voted 99.6% in favor of the company's compensation plans, days after Swiss voters approved sweeping new restrictions on executive pay. Report